Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide
Drugs
.
2015 Jun;75(9):931-3.
doi: 10.1007/s40265-015-0404-z.
Authors
Andrew J Krentz
1
,
Ken Fujioka
,
Marcus Hompesch
Affiliation
1
Profil Institute for Clinical Research, 855 3rd Avenue, Suite 4400, Chula Vista, CA, USA, andrew.krentz@profilinstitute.com.
PMID:
25963328
DOI:
10.1007/s40265-015-0404-z
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Anti-Obesity Agents / adverse effects
Anti-Obesity Agents / therapeutic use*
Drug Approval*
Humans
Obesity / drug therapy*
Substances
Anti-Obesity Agents